Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rapid Outpatient Low-dose Initiation of Buprenorphine for Individuals With OUD Using Fentanyl
NCT06379984Phase 2Recruiting
- Sponsor
- University of Pennsylvania
- Start
- May 2025
- Primary completion
- Dec 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of v1003 in opioid use disorder (OUD), sponsored by University of Pennsylvania. Started May 2025; status: recruiting.
02
Drugs
v1003
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT06379984.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06379984.